… all aspects of COVID-19 therapeutics. We explore challenges that have stymied COVID-19
drug development and highlight important unmet needs. We examine key therapeutic classes …

… coronavirus disease 2019 (COVID-19) illness were available within a year of the pandemic
being declared but there remained an urgent need for therapeutics to … of COVID-19 therapies …

… therapeutics against SARS-CoV-19. We intend for this review to familiarize readers with the
toxicities of potential therapeutics for COVID-19 … knowledge of novel therapeutics as publicly …

… effective therapeutic approaches and … COVID-19 epidemiology, structure, molecular
mechanisms of infection, pathophysiology, diagnosis, and different developmental therapeutic …

… therapeutic levels. In a phase 2/3 trial, 2246 nonhospitalized participants with COVID-19 who
… -ritonavir for treatment of mild to moderate COVID-19 in adult and pediatric patients (age ≥…

… Fig 1 Graphical summary of the main mechanisms of action for the therapeutic classes … ,
suggesting a potential therapeutic role also in this category of critically ill COVID-19 patients (280…

… течением COVID-19, а также об отсутствии аналогичного преимущества при крайне
тяжелом течении COVID-19, … пациентов с тяжелым и крайне тяжелым течением COVID-19. …

… and preventing novel coronavirus disease 2019 (COVID-19). … COVID-19 crisis and identified
many candidate therapeutics. … candidate therapeutics have borne out during COVID-19. …

… coronavirus disease 2019 (COVID-19) requires an urgent deployment of advanced therapeutic
… biological therapeutics. This strategy directs the safe and effective delivery of available …

… therapeutic agent for covid management. In this review, a consolidated summary of the
therapeutic … along with an overview of effective management of post COVID-19 complications. …